GLP-1 Coverage Guide is a private website. We are not Medicare, the Centers for Medicare & Medicaid Services (CMS), or any government agency, and we are not affiliated with or endorsed by them.
Text size:

The $50 copay, explained properly

Short answer: Under the Medicare GLP-1 Bridge, you pay a flat $50 for each one-month fill of Wegovy, Zepbound (KwikPen), or Foundayo — no deductible, same price all year. But because the program runs outside your Part D plan, the $50 never counts toward your out-of-pocket cap, and Extra Help doesn't reduce it.

Program facts last verified against CMS: July 21, 2026

The Bridge sits outside your Part D plan: your plan's deductible, out-of-pocket cap, and Extra Help apply to your other prescriptions but never touch the flat $50 Bridge copay.Your Part D drug planYour other prescriptions live hereDeductible appliesPayments count toward the ~$2,100 capExtra Help (LIS) lowers costsThese two never touchGLP-1 Bridge$50flat, every monthno deductible · never countstoward the cap · Extra Helpdoesn’t change it
Why the program’s cost rules surprise people: the Bridge runs beside your drug plan, not inside it.

What the $50 buys, and what it doesn't touch

The Bridge operates as its own nationwide program through a central processor administered by Humana — it is not a benefit inside your drug plan. That design is why no plan opt-in is needed and no deductible applies: your plan's cost-sharing rules simply never see these fills.

The same design produces the program's three cost quirks. First, the $50 payments don't accumulate toward your Part D out-of-pocket cap (about $2,100 in 2026), so they never trigger the catastrophic phase where covered drugs become free. Second, Extra Help (the Low-Income Subsidy) doesn't apply — everyone pays the same $50. Third, the fills don't interact with your plan's formulary, tiers, or step-therapy rules at all.

The annual math

Twelve months at $50 is $600 a year — for medications that run hundreds of dollars per month at retail. For most eligible people this is by far the cheapest access path to these drugs that has ever existed in Medicare. The chief caveat is time: the program ends December 31, 2027, so the earlier therapy starts, the more months of the $50 rate you can use.

Take the 2-minute eligibility check →

Common questions

Is the $50 per prescription or per month?

Per one-month fill of a covered drug. A year of continuous therapy costs $600.

Does the $50 count toward my Part D out-of-pocket cap?

No. The program sits outside Part D, so these payments never accumulate toward the annual cap.

Can my pharmacy charge me more than $50?

For a covered product with an approved prior authorization at a participating pharmacy, the program copay is $50. If you're quoted something different, ask the pharmacist to check the fill is processing under the Bridge — the Zepbound KwikPen-only rule is a common source of surprises.

Related

Program-fact sources: CMS — Medicare GLP-1 Bridge · KFF